Skip to main content

Table 3 Statistical significance of change in central retinal thickness and BCVA between baseline/end of follow-up. (Patients who completed 6 months of follow-up)

From: A cross-sectional study of submacular thickening in intermediate uveitis and determination of treatment threshold

 

Baseline

6-months

p

Untreated patients

 Central foveal thickness (μm)

179 ± 18

181 ± 29

0.561

 BCVA (LogMAR)

0.024 ± 0.085

0.015 ± 0.060

0.644

Treated patients

 Central foveal thickness (μm)

325 ± 122

209 ± 86

0.0004

 BCVA (LogMAR)

0.222 ± 0.249

0.087 ± 0.125

0.0075

  1. p-values derived from Wilcoxon matched pairs test